To Download a copy of the presentation click here.
To Download a copy of the Q&A Responses here.
For more information on this topic, please visit the Real Time Learning Network
*This call was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this call does not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.
Topics and Featured Experts: All About Paxlovid; Plus Variants Update
Welcome/Introductions
Sue Visser, DrPH, MS (Moderator)
Associate Director for Policy & Extramural Program
Division of Vector-Borne Diseases
National Center for Emerging & Zoonotic Infectious Diseases
U.S. Centers for Disease Control and Prevention
Variants Update
Carolyn Gould, MD, MSCR
CAPT, U.S. Public Health Service
Chief Medical Officer
CDC COVID-19 Response
U.S. Centers for Disease Control and Prevention
All About Paxlovid
Introduction & Background
Derek Eisnor, MD
Medical Officer, Division of Clinical Development
Biomedical Advanced Research and Development Authority
COVID-19 Allocation and Distribution Lead
U.S. Department of Health and Human Services
Clinical Case Scenarios
George A. Diaz, MD
Infectious Diseases
Providence Regional Medical Center
Benjamin A. Miko, MD
Assistant Professor of Medicine
Columbia University Medical Center
Kimberly Scarsi, PharmD, MS, FCCP, BCPS
Department of Pharmacy Practice and Science
College of Pharmacy
University of Nebraska Medical Center
Lessons Learned from the HIV/Ritonavir Experience
Melanie A. Thompson, MD
Co-Chair, HIVMA/IDSA HIV Primary Care Guidance Panel
AIDS Research Consortium of Atlanta
Additional Considerations
Derek Eisnor, MD
Medical Officer, Division of Clinical Development
Biomedical Advanced Research and Development Authority
COVID-19 Allocation and Distribution Lead
U.S. Department of Health and Human Services
Q&A and Discussion – All Presenters Plus:
Cristina Miglis, PharmD, MSc, BCPS
Clinical Pharmacologist
U.S. Food and Drug Administration
Mario Sampson, PharmD
Clinical Pharmacology Reviewer
U.S. Food and Drug Administration
